Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Pandoraon Dec 18, 2020 5:37pm
270 Views
Post# 32145346

RE:RE:RE:TLT should soon join this list

RE:RE:RE:TLT should soon join this list
newdaydawning wrote: TLT and AGN need to make their case to NRC. TLT's case may be stronger because it involves a partnerhship with the University of Manitoba. And let's be fair, Algernon's solution is incremental compared to TLT's innovation, which is game changing.

Pandora wrote:
newdaydawning wrote: https://www.canada.ca/en/national-research-council/news/2020/12/national-research-council-of-canada-supports-development-of-4-covid-19-therapeutic-candidates.html


And an outfit like Algernon Pharmaceuticals with their drug Ifenprodil which is currently in a Phase 2/3 trial is not on the list??




It may be incremental in total scope but if you were in the hospital today it could be given to you with a very reasonable chance of success in improving your condition. TLT's "innovation" is nowhere near that stage yet. Death rates today, especially in the U.S., suggest someone needs to get off their butts and get something moving now in the way of therapeutics in an emergency use basis. I have mentioned that more than a couple of times. It just p---es me off daily as I see the numbers coming out. They keep nattering vaccine, vaccine, vaccine, testing, testing, testing -- where the hell is the medicine that will keep these affected people from dying? Just culling the herd a little while we wait? Those of us that have the 'c' painted on us may be more concerned than others.
<< Previous
Bullboard Posts
Next >>